Apr 14, 2025, 12:04

The AACR-Novocure Cancer Research Grant

The AACR-Novocure Cancer Research Grant is designed to support independent investigators conducting innovative research on Tumor Treating Fields (TTFields)—a non-invasive cancer therapy using alternating electric fields to disrupt cancer cell division. These grants aim to expand the understanding of TTFields mechanisms and accelerate their integration into cancer treatment strategies. Proposals may be basic or translational, with priority given to projects transitioning TTFields research into in vivo systems or clinical applications.

Eligibility Criteria:

Must be an AACR Active Member in good standing (or apply before deadline).
Must be an independent investigator with a doctoral degree (PhD, MD, MD/PhD, or equivalent).
Cannot be a current or past recipient of an AACR-Novocure TTFields Research Grant.
Current AACR grantees may apply only if their current grant ends before December 1, 2025, and final reports are submitted.
Employees/subcontractors of U.S. government or private industry cannot apply (but may serve as collaborators without receiving funds).
No citizenship restrictions (applicants must have visa status permitting completion of project if applying from outside their home country).

Funding Details:

Amount: 350,000 USD.
Duration: 3 years.
Use of Funds: May be used for salary, benefits, supplies, equipment, travel, publication fees, and indirect costs.
Note: Experimental design must incorporate the Inovitro® system (provided by Novocure if needed).

Deadline:

Application Due: June 30, 2025, at 1:00 PM U.S. Eastern Time.
Start of Grant Term: December 1, 2025.
Decision Date: September 2025.

Further Information:

Apply via ProposalCentral.
Contact AACR’s Research and Grants Administration at [email protected] for eligibility and submission questions.
For membership support: [email protected].

AACR AACR grants cancer cancer cell division cancer innovation cancer research funding cancer treatment electric field therapy Inovitro system non-invasive therapy Novocure OncoDaily Oncology oncology research translational research TTFields Tumor Treating Fields

Senate President Passes Away After Brave Battle with Cancer: Dominick J. Ruggerio

Where to Study to Become ASCO President: 2025 Institutional Rankings

Yelak Biru: UK grants first approval for Blenrep in multiple myeloma

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

Dr. Don Dizon and Dr. Nathan Pennell Reflect on the Evolution of the ASCO Educational Book